ArticleNeuropsychiatric disease and treatment2020

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter].

Sheng-Jun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.